107 related articles for article (PubMed ID: 2707158)
21. Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition.
Krauss RM; Grunfeld C; Doerrler WT; Feingold KR
Endocrinology; 1990 Sep; 127(3):1016-21. PubMed ID: 2387245
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte growth factor stimulates synthesis of lipids and secretion of lipoproteins in rat hepatocytes.
Kaibori M; Kwon AH; Oda M; Kamiyama Y; Kitamura N; Okumura T
Hepatology; 1998 May; 27(5):1354-61. PubMed ID: 9581691
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of hepatic triglyceride formation by clofibrate.
Adams LL; Webb WW; Fallon HJ
J Clin Invest; 1971 Nov; 50(11):2339-46. PubMed ID: 5096518
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of apolipoprotein B secretion, but not lipid, by tumor necrosis factor-alpha in rat hepatocyte cultures in the absence of extracellular fatty acids.
Bartolomé N; Rodríguez L; Martínez MJ; Ochoa B; Chico Y
Ann N Y Acad Sci; 2007 Jan; 1096():55-69. PubMed ID: 17405916
[TBL] [Abstract][Full Text] [Related]
25. Fish oil-feeding prevents perfluorooctanoic acid-induced fatty liver in mice.
Kudo N; Kawashima Y
Toxicol Appl Pharmacol; 1997 Aug; 145(2):285-93. PubMed ID: 9266801
[TBL] [Abstract][Full Text] [Related]
26. A low-protein, high-carbohydrate diet increases de novo fatty acid synthesis from glycerol and glycerokinase content in the liver of growing rats.
Menezes AL; Pereira MP; Buzelle SL; Dos Santos MP; de França SA; Baviera AM; Andrade CM; Garófalo MA; Kettelhut Ido C; Chaves VE; Kawashita NH
Nutr Res; 2013 Jun; 33(6):494-502. PubMed ID: 23746566
[TBL] [Abstract][Full Text] [Related]
27. Differential metabolic responses to tumor necrosis factor with increase in age.
Mondon CE; Starnes HF
Metabolism; 1992 Sep; 41(9):970-81. PubMed ID: 1518426
[TBL] [Abstract][Full Text] [Related]
28. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance.
Feingold KR; Staprans I; Memon RA; Moser AH; Shigenaga JK; Doerrler W; Dinarello CA; Grunfeld C
J Lipid Res; 1992 Dec; 33(12):1765-76. PubMed ID: 1479286
[TBL] [Abstract][Full Text] [Related]
29. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection.
Hellerstein MK; Grunfeld C; Wu K; Christiansen M; Kaempfer S; Kletke C; Shackleton CH
J Clin Endocrinol Metab; 1993 Mar; 76(3):559-65. PubMed ID: 8445011
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of eicosapentaenoic acid and oleic acid on lipid synthesis and secretion by HepG2 cells.
Homan R; Grossman JE; Pownall HJ
J Lipid Res; 1991 Feb; 32(2):231-41. PubMed ID: 2066660
[TBL] [Abstract][Full Text] [Related]
31. Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c.
Zhang J; Tan Y; Yao F; Zhang Q
Mol Med Rep; 2012 Oct; 6(4):815-20. PubMed ID: 22858825
[TBL] [Abstract][Full Text] [Related]
32. Essential fatty acid deficiency and plasma triglyceride turnover in rats.
Huang MT; Williams MA
Am J Physiol; 1980 May; 238(5):E499-505. PubMed ID: 7377344
[TBL] [Abstract][Full Text] [Related]
33. Metabolic regulation as a control for lipid disorders. II. Influence of (--)-hydroxycitrate on genetically and experimentally induced hypertriglyceridemia in the rat.
Sullivan AC; Triscari J; Spiegel JE
Am J Clin Nutr; 1977 May; 30(5):777-84. PubMed ID: 857644
[TBL] [Abstract][Full Text] [Related]
34. Norethindrone acetate inhibition of triglyceride synthesis and release by rat hepatocytes.
Cheng DC; Wolfe BM
Atherosclerosis; 1983 Jan; 46(1):41-8. PubMed ID: 6838693
[TBL] [Abstract][Full Text] [Related]
35. Increased hepatic triacylglycerol secretion in fasted rats with ventromedial hypothalamic lesions.
Lovo A; Hustvedt BE
Biochim Biophys Acta; 1975 Oct; 409(1):51-8. PubMed ID: 1182192
[TBL] [Abstract][Full Text] [Related]
36. Halofenate and clofibrate: mechanism of hypotriglyceridemic action in the rat.
Cenedella RJ; Crouthamel WG
J Lipid Res; 1976 Mar; 17(2):156-66. PubMed ID: 1270931
[TBL] [Abstract][Full Text] [Related]
37. Role of cytokines in inducing hyperlipidemia.
Feingold KR; Grunfeld C
Diabetes; 1992 Oct; 41 Suppl 2():97-101. PubMed ID: 1526345
[TBL] [Abstract][Full Text] [Related]
38. Induction of fatty liver by fasting in suncus.
Yasuhara M; Ohama T; Matsuki N; Saito H; Shiga J; Inoue K; Kurokawa K; Teramoto T
J Lipid Res; 1991 Jun; 32(6):887-91. PubMed ID: 1940621
[TBL] [Abstract][Full Text] [Related]
39. Dimethyl sulfoxide enhances lipid synthesis and secretion by long-term cultures of adult rat hepatocytes.
De La Vega FM; Mendoza-Figueroa T
Biochimie; 1991 May; 73(5):621-4. PubMed ID: 1764509
[TBL] [Abstract][Full Text] [Related]
40. Substrate incorporation into hepatic lipids and proteins in vitro in patients with pre-beta hyperlipoproteinemia.
Stakeberg H; Scherstén T
Acta Med Scand; 1975 Mar; 197(3):217-23. PubMed ID: 1124672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
